UPDATE : Monday, February 17, 2020
Macrogen, Microba to cooperate on microbiome research by Lee Han-soo 2019-03-19 11:14
Daewoong wins right to sell TerahVax’s typhoid fever vaccine by Lee Han-soo 2019-03-19 11:14
Hanmi, Santen sign co-promotion accord for dry eye treatments by Lee Han-soo 2019-03-18 17:46
Dong-A ST to market Suganon in India by Lee Han-soo 2019-03-18 15:03
Merz’ check against Medytox: ‘Xeomin is the only pure toxin’ by Jeong Sae-im 2019-03-18 15:03
Hanmi’s US partner yanks BLA application for Rolontis after FDA demands more data by Lee Han-soo 2019-03-18 14:23
Reimbursement for orphan drug Spinraza imminent by Kim Yun-mi 2019-03-18 12:02
Handok gets shares in TRIGR Therapeutics by Lee Han-soo 2019-03-18 12:02
Korean patients lack knowledge about risk of resistance development by BTX by Lee Han-soo 2019-03-15 15:39
Dong-A ST slapped with ₩13.8 billion penalty for bribing doctors by Kwak Sung-sun 2019-03-15 15:38
Theragen’s Lou Gehrig's disease treatment wins government support by Lee Han-soo 2019-03-15 13:21
SK Chemicals executive arrested for destroying evidence in humidifier sterilizers case by Jeong Sae-im 2019-03-15 11:41
Pharmbio Korea to develop antifungal drug with BioSynectics’ nanotechnology by Lee Han-soo 2019-03-13 17:48
Daewoong to enter P3 trial for Nabota in China by Lee Han-soo 2019-03-13 15:43
Regulator OKs Yuyu’s P2 clinical trial into dry eye treatment by Lee Han-soo 2019-03-13 12:43
Tecentriq becomes 1st immunotherapy OKed for specific breast cancer by Kim Yun-mi 2019-03-13 12:43
GemVax & KAEL completes patient enrollment for P2 clinical trial into GV1001 by Lee Han-soo 2019-03-13 10:49
Dong-A ST’s erectile dysfunction treatment improves postmicturition dribbling by Lee Han-soo 2019-03-12 18:02
ImmuneOncia ends P1 clinical trials for solid cancer treatment by Lee Han-soo 2019-03-12 17:46
Drugmakers to name new CEOs, enhance ownership by Jeong Sae-im 2019-03-12 16:17
Back to Top